Neuraxis NRXS
NYSE NRXS
$7.12 +0.03 (+0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Net Equity Issued and Repurchased (2023 - 2026)

Updated

Neuraxis (NRXS) reported Net Equity Issued and Repurchased of $2.31 million for Q1 2026, down 15.2% from the prior quarter.

Analysis

Neuraxis (NRXS) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Neuraxis' Net Equity Issued and Repurchased came in at $5.04 million; for FY2025, it came in at $7.73 million.

  • By year, Net Equity Issued and Repurchased came in at $26,180 in FY2024 (-99.5%) and $4.85 million in FY2023.
  • The Q1 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn -
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 3.00 Mn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn -
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 65.60 Mn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 20.00 Mn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn -
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 5.00 Mn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 53.80 Mn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn -
10 Neuraxis 88.40 Mn 63.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.31 Mn
Dec 31, 2025 2.73 Mn
Mar 31, 2024 26,180.00
Dec 31, 2023 -617,185.00
API Access

Neuraxis Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NRXS&period=max&api_key=YOUR_API_KEY